Atlas Trials

Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone

Clinical trial NCT00493766 · TERMINATED

Trial details

NCT number
NCT00493766
Sponsor
Novartis Pharmaceuticals
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Hormone Refractory Prostate Cancer
Start date
2006-05-01
Primary completion
2008-07-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.